Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dusheiko

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Journal of Viral Hepatitis|December 18, 2008
The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitisP T F Kennedy, A J Gehring, A Nowbath, et al.
British Journal of Haematology|March 1, 1993
Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia majorS M Donohue, B Wonke, A V Hoffbrand, et al.
Gastroenterology|March 1, 1995
Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiencyM S Smith, A D Webster, A P Dhillon, et al.
Transplantation|August 15, 2001
The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosisG V Papatheodoridis, S Davies, A P Dhillon, et al.
The Journal of General Virology|April 1, 1993
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversityP Simmonds, F McOmish, P L Yap, et al.
Transplantation|September 26, 2000
Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-upD Mutimer, G Dusheiko, C Barrett, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 24, 2001
Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramersF Lechner, J Sullivan, H Spiegel, et al.
Gut|August 14, 1999
Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimensG V Papatheodoridis, S G Barton, D Andrew, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2001
Guidelines on the diagnosis, management and prevention of hepatitis in haemophiliaM Makris, T Baglin, G Dusheiko, et al.
Lancet (London, England)|November 2, 1996
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosisL Grellier, D Mutimer, M Ahmed, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of Viral Hepatitis|December 18, 2008
The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitisP T F Kennedy, A J Gehring, A Nowbath, et al.
British Journal of Haematology|March 1, 1993
Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia majorS M Donohue, B Wonke, A V Hoffbrand, et al.
Gastroenterology|March 1, 1995
Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiencyM S Smith, A D Webster, A P Dhillon, et al.
Transplantation|August 15, 2001
The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosisG V Papatheodoridis, S Davies, A P Dhillon, et al.
The Journal of General Virology|April 1, 1993
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversityP Simmonds, F McOmish, P L Yap, et al.
Transplantation|September 26, 2000
Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-upD Mutimer, G Dusheiko, C Barrett, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 24, 2001
Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramersF Lechner, J Sullivan, H Spiegel, et al.
Gut|August 14, 1999
Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimensG V Papatheodoridis, S G Barton, D Andrew, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2001
Guidelines on the diagnosis, management and prevention of hepatitis in haemophiliaM Makris, T Baglin, G Dusheiko, et al.
Lancet (London, England)|November 2, 1996
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosisL Grellier, D Mutimer, M Ahmed, et al.
Pageof 8